logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 19 of 19 Items
Showing 1 - 19 of 19 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Generating evidence to improve the response to neglected diseases: how operational research in a Médecins Sans Frontières Buruli ulcer treatment programme informed international management guidance

O'Brien DP, Ford NP, Vitoria M, Asiedu K, Calmy A,  et al.
2015-11-12 • PLOS Neglected Tropical Diseases
2015-11-12 • PLOS Neglected Tropical Diseases
Journal Article
|
Research

Novel transdisciplinary methodology for cross-sectional analysis of snakebite epidemiology at national scale

Alcoba G, Ochoa C, Martins SB, Ruiz de Castañeda R, Bolon I,  et al.
2021-02-12 • PLOS Neglected Tropical Diseases
2021-02-12 • PLOS Neglected Tropical Diseases
BACKGROUND
Worldwide, it is estimated that snakes bite 4.5-5.4 million people annually, 2.7 million of which are envenomed, and 81,000-138,000 die. The World Health Organization repo...
Journal Article
|
Research

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.<...
Journal Article
|
Research

Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria

Ashley EA, Touabi M, Ahrer M, Hutagalung R, Htun K,  et al.
2009-10-27 • Malaria Journal
2009-10-27 • Malaria Journal
BACKGROUND: In areas where non-falciparum malaria is common rapid diagnostic tests (RDTs) capable of distinguishing malaria species reliably are needed. Such tests are often based on the...
Journal Article
|
Research

Prevalence of buruli ulcer in Akonolinga health district, Cameroon: Results of a cross sectional survey

Porten K, Sailor K, Comte E, Njikap A, Sobry A,  et al.
2009-06-23 • PLOS Neglected Tropical Diseases
2009-06-23 • PLOS Neglected Tropical Diseases
BACKGROUND: Buruli ulcer (BU) is a chronic, indolent necrotizing disease of the skin and underlying tissues caused by Mycobacterium ulcerans, which may result in functional incapacity. I...
Journal Article
|
Research

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: The role of Médecins Sans Frontières

Guthmann JP, Checchi F, van den Broek IVF, Balkan S, Van Herp M,  et al.
2008-08-05 • PLOS Medicine
2008-08-05 • PLOS Medicine
Journal Article
|
Research

Snakebite epidemiology and health-seeking behavior in Akonolinga health district, Cameroon: Cross-sectional study

Alcoba G, Chabloz M, Eyong J, Wanda F, Ochoa C,  et al.
2020-06-25 • PLOS Neglected Tropical Diseases
2020-06-25 • PLOS Neglected Tropical Diseases
BACKGROUND
Snakebite envenoming causes 81,000-138,000 annual human deaths and pain, terror, or disability in 4.5-5.4 million victims. Accurate community-based epidemiological data is...
Journal Article
|
Research

Impact of Human Immunodeficiency Virus on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon

Christinet V, Rossel L, Serafini M, Delhumeau C, Odermatt P,  et al.
2014-04-26 • Open Forum Infectious Diseases
2014-04-26 • Open Forum Infectious Diseases
Abstract
Background.  Buruli ulcer is the third most common mycobacterial disease after tuberculosis and leprosy and is particularly f...
Journal Article
|
Research

Knowledge, attitude and practices of snakebite management amongest health workers in Cameroon: Need for continuous training and capacity building

Taieb F, Dub T, Madec Y, Tondeur L, Chippaux JP,  et al.
2018-10-25 • PLOS Neglected Tropical Diseases
2018-10-25 • PLOS Neglected Tropical Diseases
Snakebite has only recently been recognized as a neglected tropical disease by the WHO. Knowledge regarding snakebites and its care is poor both at the population level, and at the healt...
Journal Article
|
Research

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Prospective efficacy monitoring of anti-malarial treatments is imperative for timely detection of resistance development. The in vivo efficacy of artesunate-amodiaquine (A...
Journal Article
|
Research

Impact of HIV on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon

Christinet V, Comte E, Ciaffi L, Odermatt P, Serafini M,  et al.
2014-05-21 • Open Forum Infectious Diseases
2014-05-21 • Open Forum Infectious Diseases
Background: Buruli ulcer (BU) is the third most common mycobacterial disease after tuberculosis and leprosy and is particularly frequent in rural West and Central Africa. However, the im...
Journal Article
|
Research

Mycobacterium ulcerans infection: control, diagnosis, and treatment

Sizaire V, Nackers F, Comte E, Portaels F
2006-05-01 • Lancet Infectious Diseases
2006-05-01 • Lancet Infectious Diseases
The skin disease Buruli ulcer, caused by Mycobacterium ulcerans, is the third most common mycobacterial disease after tuberculosis and leprosy and mainly affects remote rural African com...
Journal Article
|
Commentary

Management of BU-HIV co-infection

O'Brien DP, Ford NP, Vitoria M, Christinet V, Comte E,  et al.
2014-06-20 • Tropical Medicine and International Health
2014-06-20 • Tropical Medicine and International Health
Buruli Ulcer (BU)-HIV co-infection is an important emerging management challenge for BU disease. Limited by paucity of scientific studies, guidance for management of this co-infection ha...
Journal Article
|
Letter

To buruli or not to buruli

Ho L, Cohn J, Comte E
2013-04-01 • Tropical Doctor
2013-04-01 • Tropical Doctor
Journal Article
|
Commentary

Treatment of chronic wounds: an issue for Africa

Comte E
2009-10-01 • European Wound Management Association Journal
2009-10-01 • European Wound Management Association Journal
Journal Article
|
Commentary

Moxifloxacin for Buruli ulcer/HIV coinfected patients: kill two birds with one stone?

O'Brien DP, Comte E, Ford NP, Christinet V, du Cros PAK
2013-09-10 • AIDS
2013-09-10 • AIDS
Journal Article
|
Short Report

Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection

Wanda F, Nkemenang P, Ehounou G, Tchaton M, Comte E,  et al.
2014-07-30 • BMC Infectious Diseases
2014-07-30 • BMC Infectious Diseases
In West and Central Africa Buruli ulcer (BU) and HIV co-infection is increasingly recognised and management of these two diseases combined is an emerging challenge for which there is lit...
Journal Article
|
Commentary

Buruli et VIH: une interaction complexe et peu étudiéee

Christinet V, Benedetto CD, Comte E, Calmy A
2012-09-01 • Revue Medicale Suisse
2012-09-01 • Revue Medicale Suisse
Journal Article
|
Commentary

The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa

O'Brien DP, Comte E, Serafini M, Ehounou G, Antierens A,  et al.
2013-12-02 • Lancet Infectious Diseases
2013-12-02 • Lancet Infectious Diseases
Despite great advances in the diagnosis and treatment of Buruli ulcer, it is one of the least studied major neglected tropical diseases. In Africa, major constraints in the management of...